Compound-23 (20 mg/kg) treatment reduced the mRNA expression of oxidative stress markers Nqo1 and Gclc in the kidneys of mice with LPS (5 mg/kg)-induced AKI, compared to mice treated with LPS alone (Figure 5A,B). This evidence concerns the gene GCLC and acute kidney injury.